Increased secretion of glucagon

No definition available.

Endpoint definition

↥
FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries Inpat., Oupat., Death

Hospital Discharge: ICD-10 E16.3
Hospital discharge: ICD-9 2514
Cause of death: ICD-10 E16.3
Cause of death: ICD-9 2514

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector E4_GLUCAGONPLUS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 E16
Name in latin Hypersecretio glucagoni

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 8 - -
Unadjusted prevalence (%) 0.00 - -
Mean age at first event (years) 38.05 - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

↥

Index endpoint: E4_GLUCAGONPLUS – Increased secretion of glucagon
GWS hits:

Survival analyses between endpoints

↥

Plot

before Increased secretion of glucagon
after Increased secretion of glucagon

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Increased secretion of glucagon

↥